Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes.

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

Katherine Ogurtsova, João Fernandes, Yadi Huang et al. · Diabetes Research and Clinical Practice · 2017 · 7K citations

Metabolic Syndrome, Diabetes Management, Global Health +8

Standards of Medical Care in Diabetes—2014

Diabetes Care · 2013 · 4.5K citations · Full text

Diabetes Management, Health Policy, Diabetes +2

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

David Whiting, Leonor Guariguata, Clara Weil et al. · Diabetes Research and Clinical Practice · 2011 · 4K citations

Obesity, Metabolic Syndrome, Diabetes Management +11

Economic Costs of Diabetes in the U.S. in 2012

Diabetes Care · 2013 · 2.2K citations · Full text

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text